MediWound (NASDAQ:MDWD) Given New $25.00 Price Target at HC Wainwright

MediWound (NASDAQ:MDWD) had its target price lowered by HC Wainwright from $28.00 to $25.00 in a report issued on Wednesday,Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock.

Separately, StockNews.com upgraded MediWound to a “sell” rating in a research report on Monday, August 5th.

MediWound Stock Up 0.1 %

Shares of MediWound stock opened at $17.47 on Wednesday. The firm has a market cap of $188.43 million, a price-to-earnings ratio of -6.02 and a beta of 0.83. The business has a fifty day simple moving average of $17.16 and a 200-day simple moving average of $17.38. MediWound has a fifty-two week low of $8.75 and a fifty-two week high of $24.00.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. Rosalind Advisors Inc. increased its holdings in MediWound by 5.7% during the 2nd quarter. Rosalind Advisors Inc. now owns 513,490 shares of the biopharmaceutical company’s stock valued at $7,969,000 after purchasing an additional 27,500 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of MediWound in the second quarter valued at $342,000. Rhumbline Advisers bought a new position in shares of MediWound in the second quarter valued at about $131,000. ARK Investment Management LLC acquired a new position in MediWound during the 3rd quarter worth about $1,806,000. Finally, MetLife Investment Management LLC bought a new stake in MediWound during the 3rd quarter worth about $89,000. Institutional investors own 46.83% of the company’s stock.

MediWound Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.